Kaiser Permanente study examines race, ethnicity, and risk of infection, hospitalization, and death.
The president and executive medical director of Washington Permanente Medical Group stressed distribution simulations and constant communications as key factors to efficient vaccine rollout.
Permanente physicians are sharing their expertise to help guide the fair and equitable distribution of COVID-19 vaccines to Kaiser Permanente members, employees, and the community.
Peter Barkett, MD, an internist with Washington Permanente Medical Group, examines the history of vaccines and how they are powerful tools to promote public health.
Kaiser Permanente’s national infectious disease leader says vaccine distribution will be key to battling new COVID-19 variants.
Family medicine physician Alex McDonald, MD, shares the reality of the pandemic on social media.
Our Vaccine Study Center will lead an effort in searching medical records for serious reactions among patients who receive the vaccine.
The Permanente Federation co-CEO tells The Wall Street Journal that intensive care units at hospitals are feeling the strain from a holiday influx of COVID-19 patients.
Kaiser Permanente’s infectious disease leader pleads with the public to limit the risk of COVID transmission to help reduce burdens on the health care system on KQED Forum.
Paul Minardi, MD, president and executive medical director of Washington Permanente Medical Group, surveys the history of pandemics and finds that infectious disease outbreaks have driven transformation and innovation in public health.